KUALA LUMPUR, Sept 27 (Bernama) -- Actylis, a leading global manufacturer and sourcing expert of critical raw materials and performance ingredients for the life sciences and specialty chemicals markets, has made its debut.
Chief Executive Officer of Actylis, Gilles Cottier said: “Actylis unites multiple industry specialists with a wide range of capabilities into a new, global enterprise with a unique hybrid approach that is greater than the sum of its parts.
“This consolidation enables us to offer customers across diverse locations and industries highly flexible, customised solutions addressing their specific needs, while assuring reliable on-time delivery of the high-quality ingredients essential to their success.”
According to a statement, the new company combines Aceto and 10 industry specialists into an integrated global ingredient powerhouse.
Actylis (“Ac-till-iss”) is the culmination of an ambitious initiative launched several years ago to address the major unmet need for better and more dependable access to critical raw materials and performance ingredients essential for the manufacture of highly regulated products in key industries.
To achieve this goal, Actylis has integrated leading specialty ingredient manufacturing and sourcing companies, including A&C, A&C Bio Buffer, Aceto, Biotron Laboratories, Cascade Chemistry, Finar, Inter-Actifs, IsleChem, Pharma Waldhof, Syntor Fine Chemicals and Talus into one company.
Their breadth of capabilities enables Actylis’ unique hybrid manufacturing and sourcing model, which provides key benefits to its customers in high-growth end markets, including pharmaceuticals, agriculture, cosmetics, nutrition and specialty chemicals.
With over 75 years of manufacturing and sourcing experience and a portfolio of GMP and non-GMP manufacturing facilities across multiple regions, Actylis offers customers the flexibility to choose from a wide range of individualised solutions, all backed by the same world-class quality, supply chain reliability and regulatory expertise.
More details at www.actylis.com.
-- BERNAMA
No comments:
Post a Comment